98-1170. Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 12 (Tuesday, January 20, 1998)]
    [Notices]
    [Page 2988]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-1170]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Ophthalmic Devices Panel of the Medical Devices Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Ophthalmic Devices Panel of the Medical Devices 
    Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on February 12 and 13, 
    1998, 8 a.m. to 5 p.m.
        Location: Parklawn Bldg., conference rooms D and E, 5600 Fishers 
    Lane, Rockville, MD.
        Contact Person: Sara M. Thornton, Center for Devices and 
    Radiological Health (HFZ-460), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-594-2053, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12396, or the world wide web at http://
    www.fda.gov. Please call the Information Line for up-to-date 
    information on this meeting.
        Agenda: On February 12, 1998, the committee will discuss specific 
    questions related to the development of contact lens extended wear 
    clinical testing guidance for 7-day extended wear, prolonged extended 
    wear beyond 7 days, and overnight use of contact lenses for 
    orthokeratology. On February 13, 1998, the committee will discuss, make 
    recommendations, and vote on a premarket approval application (PMA) for 
    a broad beam excimer laser for the correction of myopia with 
    astigmatism using laser in-situ keratomileusis. The committee will also 
    discuss, make recommendations, and vote on a PMA for a scanning excimer 
    laser for the correction of myopia with astigmatism using 
    photorefractive keratectomy.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by February 6, 
    1998. Oral presentations from the public will be scheduled between 
    approximately 8:30 a.m. and 9:30 a.m. on February 12 and 13, 1998. Time 
    allotted for each presentation may be limited. Those desiring to make 
    formal oral presentations should notify the contact person before 
    February 2, 1998, and submit a brief statement of the general nature of 
    the evidence or arguments they wish to present, the names and addresses 
    of proposed participants, and an indication of the approximate time 
    requested to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: January 12, 1998.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 98-1170 Filed 1-16-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
01/20/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-1170
Pages:
2988-2988 (1 pages)
PDF File:
98-1170.pdf